WP1122
| CAS No. | 1204310-73-5 | Cat. No. | BCP49214 |
| Name | WP1122 | ||
| Synonyms | WP-1122;WP 1122; | ||
| Formula | C10H16O7 | M. Wt | 248.23 |
| Description | WP-1122(WP 1122) is a candidate drug to treat SARS-COV-2(COVID-19) .2-DG completely prevented SARS-CoV–2 replication in Caco–2 cells. Glycolysis is a process by which cells convert glucose into energy and infected (host) cells are induced by viruses to dramatically increase their dependence on glycolysis. WP1122 is a prodrug of 2-DG whereby chemical elements are added to 2-DG to improve its delivery in vivo. | ||
| Pathways | Microbiology/Virology | ||
| Targets | SARS CoV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.